The pharmaceutical field is seeing a important shift in glucose treatment with the emergence of GLP-1 patches. These revolutionary vehicles offer a likely easy choice to subcutaneous injections for individuals managing diabetes. By bypassing the requirement for frequent needles, GLP-1 skin devices promise to improve patient compliance and complete